The people behind Synthyra

Science depth.Product execution.Systems-level ambition.

Our team brings together protein science, machine learning, startup operations, biomedical engineering, and computational thinking to turn biological relationships into working products.

Synthyra is built as a public-benefit company, where products fund foundational science.

Leadership

Building the science and the company.

The operators turning Synthyra's systems-biology platform into products, partnerships, and deployed infrastructure.

Logan Hallee, PhD

Chief Scientific Officer

Science & platform direction

Trained in molecular biology and mathematics, Logan earned his PhD in bioinformatics data science with a focus on machine learning. He is the architect of Synthyra's interaction engine and directs the company's science and platform strategy.

Braydon McCormick, PhD

Chief Executive Officer & Business Development

Pilots, partnerships & investors

A startup operator with 15 years of experience across operations, business development, pilots, and investor relationships.

David Bichara

Chief Operating Officer & Chief Technology Officer

Product & infrastructure

A software and biomedical engineer responsible for product, infrastructure, API development, and deployment.

Advisors

Guided by accomplished scientists, technologists, and biotech entrepreneurs.

Their experience spans tissue engineering, computational thinking, and precision medicine.

Jason Gleghorn, PhD

Founding Advisor

Professor at the University of Delaware. He develops organ-on-chip and microfluidic tissue models for drug screening and studies how mechanical forces guide tissue development. He was named a 2018 Cellular and Molecular Bioengineering Young Innovator and joined UD's inaugural Innovation Ambassador cohort.

Diane Heiser, PhD

Advisor

A biotech entrepreneur and translational-research executive who co-founded Notable Labs and served as its Chief Scientific Officer and Chief Technology Officer. There, she built an automated personalized-medicine platform for blood cancers. She has advanced precision-medicine programs from preclinical through clinical stages and advises emerging techbio teams.

Build with a team that sees the whole system.

Talk with Synthyra about turning protein relationships into faster, testable biological decisions.

Contact the team

.css-13o7eu2{display:block;}Science depth.Product execution..css-1k4zs6r{display:block;background-image:linear-gradient(to right, var(--chakra-colors-cyan-400), var(--chakra-colors-purple-400));color:transparent;-webkit-background-clip:text;background-clip:text;}Systems-level ambition.